The frequency of APOL1 risk variants tends to be high in Ghana and Nigeria21 and our data show a lower prevalence of chronic kidney disease in Ghana and Burkina Faso with a higher prevalence in South Africa, where APOL1 risk variants are less common. This evidence concerns the gene APOL1 and chronic kidney disease.